News
Transgender and non-binary US distance runner Nikki Hiltz criticized World Athletics' plans to introduce gene testing for ...
Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC).. If you have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback